Product
Veledimex
1 clinical trial
1 indication
Indication
GlioblastomaClinical trial
A Phase II Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab-rwlc (Libtayo®) in Subjects With Recurrent or Progressive GlioblastomaStatus: Completed, Estimated PCD: 2021-08-05